DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)

Clinical trial NCT04825834 · COMPLETED

Trial details

NCT number: NCT04825834
Sponsor: Delfi Diagnostics Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Lung Cancer Head and Neck Cancer Esophageal Cancer Bladder Cancer Kidney Cancer Stomach Cancer Colorectal Cancer Pancreas Cancer Liver Cancer Skin Cancer

Start date: 2021-03-22
Primary completion: 2025-07-15
Enrollment: 2992

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.